ApoE genotype accounts for the vast majority of AD risk and AD pathology

This publication has 60 references indexed in Scilit:

• Neuroplasticity in Alzheimer's disease
  Journal of Neuroscience Research, 2002
• The Reliability Theory of Aging and Longevity
  Journal of Theoretical Biology, 2001
• Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic Mice
  The American Journal of Pathology, 2000
• High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes
  Experimental Neurology, 1998
• Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
  Nature Genetics, 1997
• Do intersections of mortality-rate and survival functions have significance?
  Experimental Gerontology, 1995
• Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
  Journal of Clinical Investigation, 1994
• Can an improved environment cause maximum lifespan to decrease? Comments on lifespan criteria and longitudinal Gompertzian analysis
  Experimental Gerontology, 1994
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
  Proceedings of the National Academy of Sciences, 1993
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
  Science, 1993